WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Ownership - Who owns Nuvectis Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nuvectis Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marlio Charles Mosseri10% Owner2025-06-205,603$7.99
$44.77kBuy
Marlio Charles Mosseri10% Owner2025-06-1828,043$8.05
$225.75kBuy
Marlio Charles Mosseri10% Owner2025-06-175,399$8.11
$43.79kBuy
Marlio Charles Mosseri10% Owner2025-05-1221,167$8.11
$171.66kBuy
Marlio Charles Mosseri10% Owner2025-05-095,395$8.98
$48.43kBuy
Marlio Charles Mosseri10% Owner2025-05-099,817$8.90
$87.41kBuy
Marlio Charles Mosseri10% Owner2025-05-099,850$8.95
$88.13kBuy
Marlio Charles Mosseri10% Owner2025-05-082,400$8.65
$20.76kBuy
Marlio Charles Mosseri10% Owner2025-05-08100$8.99
$899.00Buy
Marlio Charles Mosseri10% Owner2025-05-08100$8.71
$871.00Buy

1 of 4

NVCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCT insiders and whales buy or sell their stock.

NVCT Shareholders

What type of owners hold Nuvectis Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ron Bentsur13.83%3,520,924$22.64MInsider
Marlio Charles Mosseri12.14%3,091,127$19.88MInsider
Enrique Poradosu6.51%1,656,319$10.65MInsider
Shay Shemesh6.45%1,643,068$10.56MInsider
Vanguard Group Inc2.62%666,805$4.29MInstitution
Blackrock Inc2.53%642,982$4.13MInstitution
Iridian Asset Management LLC1.46%372,717$2.40MInstitution
Baldwin Wealth Partners LLC1.38%350,461$2.25MInstitution
Geode Capital Management LLC1.12%285,332$1.83MInstitution
Michael J. Carson0.55%138,918$893.24kInsider

1 of 3

NVCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCT12.68%40.90%Net BuyingNet Buying
CYBN35.99%0.00%
CRDF43.00%26.32%Net BuyingNet Buying
NKTX62.27%37.73%Net SellingNet Selling
BHST0.62%0.00%
View Top Biotech Stocks

Nuvectis Pharma Stock Ownership FAQ

Who owns Nuvectis Pharma?

Nuvectis Pharma (NASDAQ: NVCT) is owned by 12.68% institutional shareholders, 40.90% Nuvectis Pharma insiders, and 46.43% retail investors. Ron Bentsur is the largest individual Nuvectis Pharma shareholder, owning 3.52M shares representing 13.83% of the company. Ron Bentsur's Nuvectis Pharma shares are currently valued at $22.64M.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.